:

Wei-Ying Jen1, Curtis A Lachowiez2, Jennifer Marvin-Peek1

  • 1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Blood cancer journal
|November 25, 2025
PubMed
概括

前线三重组疗法对急性髓性白血病 (AML) 患者有前途,不适合进行密集化疗,改善缓解率. 由于潜在的毒性,仔细调整剂量和监测至关重要.